Collaboration in Crisis: The Impact of Covid-19 on Non-Communicable Diseases

This webinar will look at the impact of Covid-19 on common non-communicable diseases such as diabetes. It will provide an opportunity to compare experiences and discuss different approaches to NCD prevention and control in the time of Covid.

The pandemic has highlighted the finely balanced relationship between communicable diseases and NCDs. Public health measures to deal with Covid-19 have been given priority over the interventions used to prevent and control NCD risk factors such as tobacco, alcohol and sugar controls and promotional campaigns for physical activity and healthy diets. They have also disrupted the regular care required by patients with NCDs.

The webinar will enable researchers to share information that can be used to inform government policies and decision-making.

The upcoming APRU Public Health Crisis Management webinar is led by The University of Sydney and in collaboration with three other APRU universities (National University of Singapore, Peking University and University of California Los Angeles).

Collaboration in Crisis: The Impact of Covid-19 on Non-Communicable Diseases (flyer)

Date and Time
18:00 – 19:30 Wednesday, March 17th 2021 (Los Angeles)
09:00 – 10:30 Thursday, March 18th 2021 (Beijing/Singapore)
12:00 – 13:30 Thursday, March 18th 2021 (Australian Eastern Daylight Time)

See a preliminary program here.

Watch the recording here.
View the presentation slides here.


This webinar is open to the public and will be recorded for those who cannot attend live.

Click the below images to find out the information of previous webinars.


APRU Disclaimer: The views, information, or opinions expressed during the Collaboration in Crisis: The Impact of Covid-19 on Non-Communicable Diseases are solely those of the individuals involved and do not necessarily represent those of The Association of Pacific Rim Universities (“APRU”) and its employees.  APRU is not responsible and does not verify for accuracy any of the information contained in the series.

Prof Joel Negin
Professor and Head, School of Public Health
Faculty of Medicine and Health, University of Sydney

Professor Joel Negin has been the Head of the School of Public Health at the University of Sydney since November 2015.
Joel graduated from Harvard and Columbia Universities and then worked for several years in sub-Saharan Africa on health and development projects before moving to Australia. In those years, he lived and worked in South Africa, Zimbabwe, Botswana and Kenya and collaborated with governments, the World Bank, academic institutions and United Nations partners.
Joel started at the School of Public Health in 2008 as a lecturer in the Master of International Public Health program and has always loved teaching and the interaction with students.
Professor Negin’s research interests include: Strengthening health systems in low and middle-income countries. He maintains collaborations in Uganda, Vietnam, Indonesia, and Fiji and maintains a passion for capacity building in the Asia-Pacific region.

Assistant Professor Wee Hwee Lin
School of Public Health and Department of Pharmacy, Faculty of Science, National University of Singapore

Talk title: A framework to evaluate the impact of infectious disease outbreak response measures on delivery of routine health services

Dr. Wee Hwee Lin is joint Assistant Professor in the Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science at the National University of Singapore. She received the International Society for Quality of Life Research (ISOQOL) Young Investigator Award in 2011 and served as an elected member of the Board of Directors of ISOQOL from 2013-2015. She was also an associate editor of Health and Quality of Life Outcomes (2012 – 2016), a BMC journal on health-related quality of life. Dr Wee is currently President of the International Society for Pharmacoeconomics and Outcomes Research Singapore Regional Chapter.
Her current work involves understanding patient preferences for high cost treatments, public preferences for pre-emptive pharmacogenetic testing and factors associated with well-being among Singaporeans.
Dr Wee’s research interests include:
Economic evaluation of health technologies and health services, and
Incorporating patient and public preferences in the design of health services and health policy

Professor Tony Kuo
Adjunct Professor
Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles

Talk title: Non-communicable disease prevention and control in the era of COVID-19

Professor Tony Kuo, M.D., M.S.H.S. directs the Division of Chronic Disease and Injury Prevention in the Los Angeles County Department of Public Health. He also serves as the Director of the Office of Senior Health for the County of Los Angeles. Dr. Kuo has more than 15 years of clinical practice experience in continuity and urgent/emergency care. His professional interests span the continuum of medicine and public health. They include undergraduate and graduate medical education; nutrition and physical activity promotion; tobacco control; cardiovascular health promotion; diabetes prevention; patient-centred care; and social programs that affect health.

Dr. Kuo received his Medical Degree from the University of Utah School of Medicine and his Master’s in Health Services from the University of California, Los Angeles (UCLA) Fielding School of Public Health. He is boarded in Family Medicine and is a Fellow of the American Academy of Family Physicians. He has joint appointments in the UCLA Fielding School of Public Health and the David Geffen School of Medicine at UCLA. Dr. Kuo also co-leads the Population Health Program at the UCLA Clinical and Translational Science Institute.

Associate Professor Melody Ding
Associate Professor Public Health, University of Sydney

Talk title: The impact of COVID 19 on physical activity

Associate Professor Melody Ding is an epidemiologist and population behavioural scientist. She works at the intersection of physical activity, epidemiology, and chronic disease prevention.
In 2012, she received her PhD from the Joint Doctoral Program in Public Health at the University of California San Diego and San Diego State University in the USA. Associate Professor Ding is passionate about and committed to improving population health through epidemiological research and behavioural change.
At an early stage of her career, she published around 100 peer reviewed papers, including in top ranked journals such as the Lancet, Nature Climate Change, and PLOS Medicine. In 2016, she led a team of top researchers in the field in launching a successful Lancet series on physical activity ( Many of her studies have contributed to informing the public about healthy living through wide media coverage around the world.
Her research interests include: Climate Change and Public Health, Chronic Disease Prevention, Built Environment, and health Issues in China.

Assistant Professor Jue LIU
School of Public Health, Peking University

Talk title: The impact of COVID-19 on diabetes in China

Dr. Liu is an assistant professor of epidemiology and biostatistics at the School of Public Health, Peking University. She gained the bachelor’s degree of Medicine in 2008 and worked in the department of gynaecology and obstetrics in Peking University First Hospital during 2008-2011. Then she gained her PhD in epidemiology and biostatistics at Peking University in 2016. Her research interests are: (1) Epidemiology of infectious diseases, (2) Prevention, control, and management on infectious diseases, (3) Maternal and child health (4) Big data research and application in health. As a principal investigator, she has leaded 8 projects, which were funded by the National Natural Science Foundation, the Ministry of Science and Technology of China, the National Health Commission of China, etc. And she has also engaged in national projects, including the National Major Scientific and Technological Special Project of China, the National Science & Technology Pillar Program, etc. She has published more than 50 papers, including Lancet Infectious Disease (IF 27.516), Lancet Global Health (IF 15.873), Bull World Health Organ (IF 6.818), etc. She is the member of big data working committee of on rehabilitation in the rehabilitation medical association of China, vice president of the Youth Committee of the Soft Tissue Oncology Branch of China Association for the Promotion of International Exchange in Healthcare, member of Expert panel of China National Health Commission on COVID-19, member of the Epidemiology Professional Committee of Beijing Preventive Medicine Association, etc.. She has awarded the first prize of the Science and Technology Award of the Chinese Preventive Medicine Association, the first prize of National Maternal and Child Health Science and Technology Award, and the Beijing May Fourth Youth Medal, Peking University Academic Innovation Award, etc.
Her research interests include: Epidemiology of infectious diseases, Prevention, control and management on infectious diseases, Maternal and child health, Big data research and application in health.